SARA VALASEK: Open Payments
NPI 1548705049 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$867 in 39 payments from 22 companies in 2025. Trend: 2023 $859 · 2024 $653 · 2025 $867
Food & beverage: $867
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 5 | $126 |
| AstraZeneca Pharmaceuticals LP | 5 | $103 |
| BeOne Medicines USA, Inc. | 3 | $66 |
| Pharmacosmos Therapeutics Inc. | 1 | $64 |
| Merck Sharp & Dohme LLC | 3 | $64 |
| E.R. Squibb & Sons, L.L.C. | 3 | $53 |
| KYOWA KIRIN, INC. | 2 | $43 |
| Geron Corporation | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
| GlaxoSmithKline, LLC. | 2 | $31 |
Products named: Enhertu, BRUKINSA, MONOFERRIC, LYNPARZA, CALQUENCE, KEYTRUDA, POTELIGEO, RYTELO.
Industry payments across NC — which companies pay providers there.
